LivaNova PLC
LIVNNASDAQHealthcare● Active
$74.80
+$2.44(+3.37%)
Market Cap$4.1B
P/E Ratio—
52W High$75.815
52W Low$41.015
LivaNova PLC (LIVN) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
LIVN · earnings · updated Jun 10, 2026
Latest Earnings
Q2 FY2026Report Date: May 6, 2026EPS Actual
$0.98
Est. $0.85 · +15.3%
Revenue
$0.36B
Est. $0.35B · +4.7%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 6, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue🔥 11-Quarter EPS Beat Streak
LIVN reports quarterly as a NASDAQ-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Next earnings date not yet announced.
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 5, 2026 | $1.08 | — | — | — | $0.38B | — |
| ▲ Q2 FY2026 | May 6, 2026 | $0.85 | $0.98 | +15.3% | $0.36B | $0.35B | +4.7% |
| ▲ Q1 FY2026 | Feb 25, 2026 | $0.80 | $0.86 | +7.5% | $0.36B | $0.35B | +2.1% |
| ▲ Q4 FY2025 | Nov 5, 2025 | $0.92 | $1.11 | +20.8% | $0.36B | $0.34B | +4.4% |
| ▲ Q3 FY2025 | Aug 6, 2025 | $0.84 | $1.05 | +25.0% | $0.35B | $0.34B | +3.0% |
| ▲ Q2 FY2025 | May 7, 2025 | $0.75 | $0.88 | +17.3% | $0.32B | $0.33B | -4.2% |
| ▲ Q1 FY2025 | Feb 25, 2025 | $0.80 | $0.81 | +1.3% | $0.32B | $0.31B | +4.3% |
| ▲ Q4 FY2024 | Oct 30, 2024 | $0.71 | $0.90 | +26.8% | $0.32B | $0.32B | -1.7% |
Q3 FY2026
Aug 5, 2026
EPS Actual
—
EPS Est.
$1.08
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 6, 2026Beat
EPS Actual
$0.98
EPS Est.
$0.85
EPS Surpr.
+15.3%
Revenue
$0.36B
Q1 FY2026
Feb 25, 2026Beat
EPS Actual
$0.86
EPS Est.
$0.80
EPS Surpr.
+7.5%
Revenue
$0.36B
Q4 FY2025
Nov 5, 2025Beat
EPS Actual
$1.11
EPS Est.
$0.92
EPS Surpr.
+20.8%
Revenue
$0.36B
Q3 FY2025
Aug 6, 2025Beat
EPS Actual
$1.05
EPS Est.
$0.84
EPS Surpr.
+25.0%
Revenue
$0.35B
Q2 FY2025
May 7, 2025Beat
EPS Actual
$0.88
EPS Est.
$0.75
EPS Surpr.
+17.3%
Revenue
$0.32B
Q1 FY2025
Feb 25, 2025Beat
EPS Actual
$0.81
EPS Est.
$0.80
EPS Surpr.
+1.3%
Revenue
$0.32B
Q4 FY2024
Oct 30, 2024Beat
EPS Actual
$0.90
EPS Est.
$0.71
EPS Surpr.
+26.8%
Revenue
$0.32B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $1.29 | $1.30 | $1.31 | 2 |
| Q3 FY2028 | $1.21 | $1.22 | $1.23 | 2 |
| Q2 FY2028 | $1.27 | $1.28 | $1.30 | 2 |
| Q1 FY2028 | $1.14 | $1.15 | $1.16 | 2 |
| Q4 FY2027 | $1.17 | $1.18 | $1.19 | 1 |
| Q3 FY2027 | $1.15 | $1.16 | $1.17 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.4B | $0.4B | $0.4B | 1 |
| Q3 FY2028 | $0.4B | $0.4B | $0.4B | 1 |
| Q2 FY2028 | $0.4B | $0.4B | $0.4B | 1 |
| Q1 FY2028 | $0.4B | $0.4B | $0.4B | 1 |
| Q4 FY2027 | $0.4B | $0.4B | $0.4B | 2 |
| Q3 FY2027 | $0.4B | $0.4B | $0.4B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 6, 2026 | +15.3% | $57.59 | $66.26 | +15.05% |
| ▲ Q1 FY2026 | Feb 25, 2026 | +7.5% | $69.05 | $70.29 | +1.80% |
| ▲ Q4 FY2025 | Nov 5, 2025 | +20.8% | $53.94 | $50.81 | -5.80% |
| ▲ Q3 FY2025 | Aug 6, 2025 | +25.0% | $42.61 | $47.36 | +11.15% |
| ▲ Q2 FY2025 | May 7, 2025 | +17.3% | $35.16 | $43.50 | +23.72% |
| ▲ Q1 FY2025 | Feb 25, 2025 | +1.3% | $49.50 | $41.70 | -15.76% |
| ▲ Q4 FY2024 | Oct 30, 2024 | +26.8% | $52.97 | $51.34 | -3.08% |
| ▲ Q3 FY2024 | Jul 31, 2024 | +17.7% | $51.30 | $49.40 | -3.70% |
Q2 FY2026+15.05%
Report Date
May 6, 2026
EPS Beat/Miss
+15.3%
Price Before
$57.59
Price After
$66.26
Q1 FY2026+1.80%
Report Date
Feb 25, 2026
EPS Beat/Miss
+7.5%
Price Before
$69.05
Price After
$70.29
Q4 FY2025-5.80%
Report Date
Nov 5, 2025
EPS Beat/Miss
+20.8%
Price Before
$53.94
Price After
$50.81
Q3 FY2025+11.15%
Report Date
Aug 6, 2025
EPS Beat/Miss
+25.0%
Price Before
$42.61
Price After
$47.36
Q2 FY2025+23.72%
Report Date
May 7, 2025
EPS Beat/Miss
+17.3%
Price Before
$35.16
Price After
$43.50
Q1 FY2025-15.76%
Report Date
Feb 25, 2025
EPS Beat/Miss
+1.3%
Price Before
$49.50
Price After
$41.70
Q4 FY2024-3.08%
Report Date
Oct 30, 2024
EPS Beat/Miss
+26.8%
Price Before
$52.97
Price After
$51.34
Q3 FY2024-3.70%
Report Date
Jul 31, 2024
EPS Beat/Miss
+17.7%
Price Before
$51.30
Price After
$49.40
Avg Beat Reaction+2.92%
Beat Rate8 / 8 quarters
Largest Move+23.72% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: LIVN ends December
LivaNova PLC (LIVN) most recently reported earnings on May 6, 2026 for Q2 FY2026, posting EPS of $0.98 — beating the analyst consensus of $0.85 by +15.3%. LIVN has beaten EPS estimates for 11 consecutive quarters.
Each quarter, investors track LIVN earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. LIVN revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
LIVN's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
LIVN earnings · 5 questionsLivaNova PLC's next earnings report is expected around TBD. LIVN typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; LIVN historically reports after market close (AMC).
LIVN earnings datewhen is LIVN earningsLIVN next earnings datewhen does LIVN report earningsLIVN earnings calendar
▸ Source: FMP · LivaNova PLC SEC filings · US GAAP · LivaNova PLC SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026